Amgen (AMGN) Tops Q4 EPS by 18c

Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.64, $0.18 better than the analyst estimate of $3.46. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.06 billion.

GUIDANCE:

Amgen sees FY2020 EPS of $14.85-$15.60, versus the consensus of $16.14. Amgen sees FY2020 revenue of $25-25.6 billion, versus the consensus of $25.5 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Spotify (SPOT) jumps 10% as Q1 revenue, gross margins beat Street's estimates
• Philip Morris International (PM) Tops Q1 EPS by 9c; raises guidance